TL;DR
This study quantifies the economic barriers to adopting long-acting injectable cabotegravir (CAB-LA) for HIV prevention among men who have sex with men (MSM) in Guangxi, China. Researchers found that while interest in the injectable is high, the median willingness to pay is only 200 CNY (~$28 USD) per month—a fraction of current market prices—and demand is highly "elastic," meaning even small price increases significantly slash potential adoption.
What Problem Does This Paper Address?
Pre-exposure prophylaxis (PrEP) is a highly effective way to prevent HIV infection, but its success depends on strict adherence. While daily oral pills (TDF/FTC) have been the standard, long-acting injectables like CAB-LA—administered once every two months—offer a "set it and forget it" alternative that eliminates the burden of daily dosing.
However, CAB-LA is expensive. In the US, it launched at over $22,000 per year. In China, where oral PrEP is often an out-of-pocket expense, the economic feasibility of switching to injectables is unknown. This paper investigates the "Willingness to Pay" (WTP) and "Price Elasticity of Demand" (PED) among MSM in Guangxi to determine what price point would actually allow for widespread public health impact.
Methods
The researchers conducted a cross-sectional study involving face-to-face interviews with 1,006 MSM recruited from a gay-friendly health consulting center in Nanning, China.
Key methodological features included:
- WTP Assessment: Participants were asked if they would use CAB-LA if it were free, then asked for the maximum monthly amount they would pay if it were not.
- Statistical Modeling: Univariate and multivariate ordinal logistic regression were used to identify demographic and behavioral factors associated with higher WTP.
- Price Elasticity of Demand (PED): The team calculated PED to measure how sensitive demand is to price changes. A PED > 1 indicates "elastic" demand, where price hikes lead to a disproportionately large drop in the number of people willing to buy the drug.
Datasets
The study relies on a primary dataset of 1,006 MSM in Guangxi, China, collected between March and July 2022.
- Demographics: 84.1% were aged 18–39; 90.6% had a high school education or higher.
- Behavioral Data: The survey captured sexual history, HIV knowledge, and prior experience with oral PrEP.
Key Insights and Ideas
- The "Affordability Gap": There is a massive chasm between what users can afford and current global market prices. The median WTP of 200 CNY/month (~$338/year) is nearly 65 times lower than the US list price.
- High Sensitivity (Elasticity): The PED was highest (3.13) when the price dropped from 600 to 500 CNY. This suggests that at higher price points, even modest discounts could triple the number of people willing to adopt the treatment.
- The "Bisexual/Unsure" Factor: Interestingly, men identifying as bisexual or unsure of their orientation had a higher WTP (aOR: 1.73) than those identifying as gay. The authors suggest this might be due to a heightened sense of responsibility to protect female partners or families, or a different perception of risk.
- Education as a Driver: Higher education was the strongest predictor of WTP (aOR: 2.21 for those with a bachelor's degree), likely reflecting both higher health literacy and higher earning potential.
Key Results
- Median WTP: 200 CNY (IQR: 100–500) per month.
- Adoption Ceiling: 84.2% of participants were unwilling to pay more than 600 CNY per month.
- Elasticity Trends: Demand is highly elastic across all tested price points:
- 600 to 500 CNY: PED = 3.13
- 500 to 400 CNY: PED = 1.64
- 400 to 300 CNY: PED = 1.33
- 300 to 200 CNY: PED = 1.17
- Positive Correlates for WTP: Younger age (18-24), higher monthly income (≥6000 CNY), and prior experience/knowledge of PrEP were all significantly associated with a higher maximum WTP.
Limitations and Future Work
- Sampling Bias: Participants were recruited from a specific health center, meaning they might be more health-conscious or have higher HIV knowledge than the general MSM population in China.
- Social Desirability Bias: Face-to-face interviews regarding sexual health and finances can lead participants to overstate their willingness to pay or follow health guidelines.
- Single-Item Metrics: Some complex variables, like perceived HIV risk, were measured with single questions rather than validated multi-item scales.
Future Work: The authors advocate for policy interventions, such as waived patent protections or government subsidies, to bring the price of CAB-LA down to the 100–200 CNY range, which would make it accessible to the vast majority of the at-risk population.
Summary updated